A panel of neuroblastoma cell lines, including CLB-BAR (amplified MYCN/ALK, ALKΔexon4-11), CLB-GE (amplified MYCN/ALK, ALK-F1174V), CLB-PE (amplified MYCN), and IMR-32 (amplified MYCN) was used to test alectinib (39, 40, 46, 47). This evidence concerns the gene ALK and neuroblastoma.